Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26FM6G9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,898
Award facts
- Contract value 100% obligated
- $26,898.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,898.11 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors, with an ultimate completion date of December 11, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems.
SKYRIZI is a biologic immunosuppressant used to treat inflammatory skin conditions such as psoriasis and plaque psoriasis. This delivery order represents routine medical supply fulfillment under AmerisourceBergen's broad global pharmaceutical support vehicle, which enables the company to supply diverse pharmaceutical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract reflects AmerisourceBergen's established position as a preferred vendor within the federal medical supply chain, supporting the DLA's pharmaceutical procurement mission for defense and military healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FM6G9?
SPE2DR26FM6G9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FM6G9 worth?
The government has obligated $26,898 on SPE2DR26FM6G9.
Is contract SPE2DR26FM6G9 an order under another contract?
Yes. SPE2DR26FM6G9 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM6G9 competed?
The extent of competition for SPE2DR26FM6G9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award